Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)

被引:0
|
作者
Ahmed Eraky [1 ]
Reuben Ben-David [1 ]
Gabriele Bignante [2 ]
Zhenjie Wu [3 ]
Linhui Wang [3 ]
Randall Lee [4 ]
Andres F. Correa [4 ]
Daniel D. Eun [4 ]
Alessandro Antonelli [5 ]
Alessandro Veccia [5 ]
Francesco Ditonno [5 ]
Firas Abdollah [6 ]
Alex Stephens [6 ]
Shane Tinsley [6 ]
Daniel Sidhom [7 ]
Chandru P. Sundaram [7 ]
Sol C. Moon [8 ]
Soroush Rais-Bahrami [8 ]
Mark L. Gonzalgo [9 ]
Omri Falik Nativ [9 ]
Francesco Porpiglia [10 ]
Daniele Amparore [11 ]
Enrico Checcucci [10 ]
Antonio Tufano [10 ]
Sisto Perdonà [11 ]
Stephan Brönimann [12 ]
Nirmish Singla [12 ]
Ottavio De Cobelli [13 ]
Matteo Ferro [13 ]
Giuseppe Simone [14 ]
Gabriele Tuderti [14 ]
Margaret F. Meagher [15 ]
Ithaar H. Derweesh [15 ]
Takashi Yoshida [16 ]
Hidefumi Kinoshita [16 ]
Raj Bhanvadia [17 ]
Ali H. Zahalka [17 ]
Vitaly Margulis [18 ]
Farshad S. Moghaddam [18 ]
Hooman Djaladat [18 ]
Riccardo Autorino [19 ]
Reza Mehrazin [19 ]
机构
[1] Icahn School of Medicine at Mount Sinai Hospital,Department of Urology
[2] One Gustave L. Levy Place,Department of Urology
[3] Rush University,Department of Urology
[4] Changhai Hospital,Department of Urology
[5] Naval Medical University,Department of Urology
[6] Fox Chase-Temple Urologic Institute,Department of Urology
[7] University of Verona,Desai Sethi Urology Institute
[8] Vattikuti Urology Institute,Division of Urology
[9] Henry Ford Hospital,Department of Surgery
[10] Indiana University,School of Medicine
[11] University of Alabama at Birmingham Heersink School of Medicine,Division of Urology
[12] University of Miami Miller School of Medicine,Department of Urology
[13] University of Turin,Department of Urology
[14] San Luigi Gonzaga Hospital,Department of Urology and Andrology
[15] Candiolo Cancer Institute,Department of Urology
[16] FPO-IRCCS,Norris Comprehensive Cancer Center, Institute of Urology
[17] Istituto Nazionale Tumori Di Napoli,undefined
[18] IRCCS “Fondazione G. Pascale”,undefined
[19] Brady Urological Institute,undefined
[20] Johns Hopkins Medicine,undefined
[21] European Institute of Oncology (IEO)-IRCCS,undefined
[22] IRCCS “Regina Elena” National Cancer Institute,undefined
[23] UC San Diego School of Medicine,undefined
[24] Kansai Medical University,undefined
[25] University of Texas Southwestern Medical Center,undefined
[26] University of Southern California,undefined
关键词
UTUC; Neoadjuvant; Adjuvant; Recurrence; Survival;
D O I
10.1007/s00345-025-05605-5
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] PROPENSITY SCORE-MATCHED ANALYSIS OF NEOADJUVANT VS. ADJUVANT THERAPY IN RENAL CELL CARCINOMA
    Cesare, Saitta
    Mimi, V. Nguyen
    Giacomo, Musso
    Kevin, Hakimi
    Dattatraya, Patil
    Hajime, Tanaka
    Luke, Wang
    Margaret, F. Meagher
    Dhruv, Puri
    Kit, Yuen
    Masaki, Kobayashi
    Shohei, Fukuda
    Giuseppe, Garofano
    Giovanni, Lughezzani
    Nicolo, Buffi
    Viraj, Master
    Ithaar, H. Derweesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [22] Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: A retrospective multicenter comparative analysis (ROBUUST collaborative analysis)
    Ditonno, F.
    Franco, A.
    Wu, Z.
    Wang, L.
    Correa, A.
    Margulis, V.
    Djaladat, H.
    Veccia, A.
    Simone, G.
    Tuderti, G.
    Derweesh, I. H.
    Abdollah, F.
    Singla, N.
    Ferro, M.
    Porpiglia, F.
    Checcucci, E.
    Amparore, D.
    Gonzalgo, M. L.
    Perdona, S.
    Tufano, A.
    Mehrazin, R.
    Sundaram, C. P.
    Antonelli, A.
    Autorino, R.
    EUROPEAN UROLOGY, 2024, 85 : S817 - S818
  • [23] ROBOTIC DISTAL URETERECTOMY FOR HIGH-RISK DISTAL URETERAL UROTHELIAL CARCINOMA: A RETROSPECTIVE MULTICENTER COMPARATIVE ANALYSIS (ROBUUST COLLABORATIVE ANALYSIS)
    Ditonno, Francesco
    Franco, Antonio
    Manfredi, Celeste
    Wu, Zhenjie
    Wang, Linhui
    Abdollah, Firas
    Finati, Marco
    Simone, Giuseppe
    Tuderti, Gabriele
    Helstrom, Emma
    Correa, Andreas
    De Cobelli, Ottavio
    Ferro, Matteo
    Porpiglia, Francesco
    Amparore, Daniele
    Tufano, Antonio
    Perdona, Sisto
    Bhanvadia, Raj
    Margulis, Vitaly
    Bronimann, Stephan
    Singla, Nirmish
    Puri, Dhruv
    Derweesh, Ithaar H.
    Mendiola, Dinno F.
    Bologna, Eugenio
    Licari, Leslie Claire
    Gonzalgo, Mark L.
    Ben David, Reuben
    Mehrazin, Reza
    Moon, Sol C.
    Rais-Bahrami, Soroush
    Young, Courtney
    Sundaram, Chandru P.
    Moghaddam, Farshad Sheybaee
    Ghoreifi, Alireza
    Djaladat, Hooman
    Antonelli, Alessandro
    Autorino, Riccardo
    JOURNAL OF UROLOGY, 2024, 211 (05): : E447 - E448
  • [24] The Role of Neoadjuvant Versus Adjuvant Therapy for Duodenal Adenocarcinoma: A National Cancer Database Propensity Score Matched Analysis
    Linden, Kimberly
    Melillo, Atlee
    Gaughan, John
    Obinero, Chioma
    Kellish, Alec
    Wozniak, Marisa R.
    Patel, Raj M.
    Pandya, Vidish
    Atabek, Umur
    Spitz, Francis
    Hong, Young K.
    AMERICAN SURGEON, 2021, 87 (07) : 1066 - 1073
  • [25] Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy
    Leow, Jeffrey J.
    Chong, Yew Lam
    Chang, Steven L.
    Valderrama, Begona P.
    Powles, Thomas
    Bellmunt, Joaquim
    EUROPEAN UROLOGY, 2021, 79 (05) : 635 - 654
  • [26] Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis
    Raoof, Mustafa
    Blakely, Andrew M.
    Melstrom, Laleh G.
    Lee, Byrne
    Warner, Susanne G.
    Chung, Vincent
    Singh, Gagandeep
    Chen, Yi-Jen
    Fong, Yuman
    CANCER MEDICINE, 2019, 8 (13): : 5881 - 5890
  • [27] Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma
    Kapoor, A.
    Gharajeh, A.
    Sheikh, A.
    Pinthus, J.
    CURRENT ONCOLOGY, 2009, 16 : S62 - S68
  • [28] THE ROLE OF NEOADJUVANT VERSUS ADJUVANT THERAPY FOR DUODENAL ADENOCARCINOMA: A NATIONAL CANCER DATABASE (NCDB) PROPENSITY SCORE MATCHED ANALYSIS
    Linden, Kimberly M.
    Melillo, Atlee M.
    John, Gaughan
    Obinero, Chioma G.
    Atabek, Umur
    Spitz, Francis
    Hong, Young
    GASTROENTEROLOGY, 2019, 156 (06) : S1408 - S1408
  • [29] DIFFERENTIAL IMPACT OF POSITIVE SURGICAL MARGIN IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA AFTER ADJUVANT AND NEOADJUVANT SYSTEMIC THERAPY: A MULTICENTER ANALYSIS
    Saitta, Cesare
    Meagher, Margaret F.
    Capitanio, Umberto
    Porpiglia, Francesco
    Antonelli, Alessandro
    Afari, Jonathan A.
    Casale, Paolo
    Tanaka, Hajime
    Nguyen, Mimi V.
    Patil, Dattatraya
    Hakimi, Kevin
    Cortes, Julian
    Roberts, Jacob
    Liu, Franklin
    Mahmood, Mirha
    Matian, Joshua
    Mansour, Mariam
    Puri, Dhruv
    Cerrato, Clara
    Yuen, Kit L.
    Kobayashi, Masaki
    Fukuda, Shohei
    Buffi, Nicolo M.
    Lughezzani, Giovanni
    Fujii, Yasuhisa
    Master, Viraj
    Tuderti, Gabriele
    Simone, Giuseppe
    Veccia, Alessandro
    Autorino, Riccardo
    Montorsi, Francesco
    Derweesh, Ithaar H.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E141 - E141
  • [30] Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC)
    Vassilakopoulou, Maria
    Rouge, Thibault de la Motte
    Colin, Pierre
    Ouzzane, Adil
    Khayat, David
    Dimopoulos, Meletios-Athanasios
    Papadimitriou, Christos A.
    Bamias, Aristotle
    Pignot, Geraldine
    Nouhaud, Francois Xavier
    Hurel, Sophie
    Guy, Laurent
    Bigot, Pierre
    Roumiguie, Mathieu
    Roupret, Morgan
    CANCER, 2011, 117 (24) : 5500 - 5508